首頁 > 市場調查報告書 > 醫療設備

傷口護理

市場調查報告書

商品編碼

1667989

植物性止血粉市場 - 全球產業規模、佔有率、趨勢、機會和預測，按類型（1g、3g、5g、其他）、按應用（手術傷口護理、一般傷口護理）、按地區和競爭細分，2020-2030 年預測

Plant-based Hemostat Powder Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (1g, 3g, 5g, Others), By Application (Surgical Wound Care, General Wound Care), By Region and Competition, 2020-2030F

出版日期: 2025年02月28日 | 出版商:

TechSci Research | 英文 181 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2024 年全球植物性止血粉市場價值為 1.8635 億美元，預計到 2030 年將達到 3.2664 億美元，複合年成長率為 9.78%。這種創新材料源自天然植物，是控制手術過程中出血的有效工具。與可能來自動物或合成來源的傳統止血劑不同，植物性止血粉提供了一種永續且生物相容性的替代品。植物性止血粉的主要優點之一是其可生物分解性。它來自植物，隨著時間的推移，會在體內自然分解，從而降低與異物相關的不良反應或併發症的風險。此特性符合日益成長的環保和永續醫療保健解決方案趨勢。此外，植物性止血粉具有優異的止血性能，可有效促進血液凝固並減少出血。這在手術中至關重要，因為精確控制出血對於確保成功的結果至關重要。這種粉末通常經過配製，以便在與血液接觸時能夠快速吸收和激活，從而能夠迅速有效地止血。另一個顯著的好處是它降低了過敏反應或免疫原性反應的風險。傳統的止血劑，尤其是來自動物來源的止血劑，可能會引發某些患者過敏反應的風險。植物替代品提供了一種低過敏性的選擇，使其適合更廣泛的患者群體並降低不良事件的可能性。此外，植物性止血粉符合尋求天然或植物衍生解決方案來滿足其醫療保健需求的患者的偏好。對於那些在醫療治療中使用動物源產品時有道德或個人考慮的人來說，此選項提供了一個可行的替代方案。除了止血特性外，植物止血粉還可能帶來其他好處。一些配方包含具有抗發炎或抗菌特性的天然化合物，進一步增強了其在外科應用中的實用性。這些額外的屬性有助於減少術後併發症並改善患者的整體治療效果。

市場概況
預測期	2026-2030
2024 年市場規模	1.8635 億美元
2030 年市場規模	3.2664 億美元
2025-2030 年複合年成長率	9.78％
成長最快的領域	手術傷口護理
最大的市場	北美洲

主要市場促進因素

對永續醫療產品的需求不斷成長，推動了全球植物性止血粉市場的發展

消費者對天然和有機產品的偏好推動了全球植物性止血粉市場的發展

主要市場挑戰

成本高

監管合規和批准阻礙了植物性止血粉市場的成長：

主要市場趨勢

擴展手術環境以外的應用

Global Plant-based Hemostat Powder Market was valued at USD 186.35 Million in 2024 and is expected to reach USD 326.64 Million in the forecast period with a CAGR of 9.78% through 2030. Plant-based hemostat powder represents a groundbreaking advancement in the field of medical hemostasis. Derived from natural plant sources, this innovative material serves as an effective tool in controlling bleeding during surgical procedures. Unlike traditional hemostatic agents that may be derived from animal or synthetic sources, plant-based hemostat powder offers a sustainable and biocompatible alternative. One of the primary advantages of plant-based hemostat powder is its biodegradability. Being sourced from plants, it naturally breaks down in the body over time, reducing the risk of adverse reactions or complications associated with foreign materials. This property aligns with the growing trend towards environmentally-friendly and sustainable healthcare solutions. Furthermore, plant-based hemostat powder exhibits excellent hemostatic properties, effectively promoting blood clotting and minimizing bleeding. This is crucial in surgical settings, where precise control over bleeding is paramount to ensure successful outcomes. The powder is often formulated to facilitate rapid absorption and activation upon contact with blood, allowing for swift and efficient hemostasis. Another significant benefit is its reduced risk of allergic reactions or immunogenic responses. Traditional hemostatic agents, especially those derived from animal sources, may pose a risk of triggering allergic reactions in some patients. Plant-based alternatives offer a hypoallergenic option, making them suitable for a broader patient population and reducing the likelihood of adverse events. Moreover, plant-based hemostat powder aligns with the preferences of patients seeking natural or plant-derived solutions for their healthcare needs. This option provides a viable alternative to those who may have ethical or personal considerations regarding the use of animal-derived products in medical treatments. In addition to its hemostatic properties, plant-based hemostat powder may also offer secondary benefits. Some formulations incorporate natural compounds with anti-inflammatory or antimicrobial properties, further enhancing its utility in surgical applications. These additional attributes can contribute to reduced post-operative complications and improved overall patient outcomes.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 186.35 Million
Market Size 2030	USD 326.64 Million
CAGR 2025-2030	9.78%
Fastest Growing Segment	Surgical Wound Care
Largest Market	North America

Key Market Drivers

Increasing Demand for Sustainable Medical Products is Driving the Global Plant based Hemostat Powder Market

The increasing demand for sustainable medical products is a pivotal driver propelling the growth of the plant-based hemostat powder market. This surge in demand is rooted in a global shift towards environmentally conscious and socially responsible healthcare practices. Patients, healthcare providers, and institutions are increasingly recognizing the importance of adopting sustainable solutions in medical treatments, and plant-based hemostat powder exemplifies this commitment to eco-friendly healthcare. One of the key advantages of plant-based hemostat powder is its eco-conscious sourcing. Derived from natural, renewable plant sources, it significantly reduces the environmental impact compared to traditional hemostatic agents, which may involve resource-intensive processes or animal-derived materials. This aligns with the broader movement towards sustainability in healthcare, where minimizing the ecological footprint of medical treatments is a top priority.

Furthermore, the production and disposal of plant-based hemostat powder often have a lower environmental impact. Manufacturing processes for plant-based materials typically involve fewer chemical inputs and generate less waste compared to synthetic or animal-derived alternatives. Moreover, being biodegradable, plant-based hemostat powder breaks down naturally over time, further minimizing its environmental footprint.

In addition to the ecological benefits, the demand for sustainable medical products is driven by the desire to reduce potential risks and sensitivities associated with conventional options. Traditional hemostatic agents, particularly those derived from animal sources, may pose risks of allergic reactions or sensitivities in certain patients. Plant-based alternatives offer a hypoallergenic option, providing a safer choice for a wider patient population.

The preference for sustainable medical products is also influenced by an increasing awareness among healthcare providers and patients about the broader health impacts of treatment choices. Patients are becoming more informed and discerning about the materials used in their healthcare, seeking options that align with their values and priorities. Plant-based hemostat powder meets this demand by offering a natural, organic alternative that resonates with individuals who prefer treatments derived from organic sources.

According to the U.S. Environmental Protection Agency (EPA), the total generation of municipal solid waste (MSW) in 2018 was 292.4 million tons, with approximately 69 million tons recycled and 25 million tons composted, resulting in a recycling and composting rate of 32.1%. This highlights the growing emphasis on recycling and sustainable practices, underscoring the importance of eco-friendly products like plant-based hemostat powders in reducing medical waste and promoting environmental sustainability.

Consumer Preference for Natural and Organic Products is Driving the Global Plant based Hemostat Powder Market

The surge in consumer preference for natural and organic products is a significant driving force behind the remarkable growth of the plant-based hemostat powder market. This shift in consumer behavior reflects a broader societal trend towards seeking healthier, more sustainable, and environmentally friendly options in various aspects of life, including healthcare. One of the primary reasons for this preference is the growing awareness of the potential risks associated with synthetic or chemically derived materials. Consumers are increasingly scrutinizing the composition of the products they use, particularly in healthcare, where safety and efficacy are paramount. Plant-based hemostat powder, derived from natural sources, provides a reassuring alternative for individuals who are wary of the potential side effects or long-term impacts of synthetic materials.

Conventional hemostatic agents, such as bovine- or porcine-derived products, can pose risks of allergic reactions or sensitivities in certain individuals. This risk is particularly pertinent for patients with known sensitivities to animal-derived proteins or compounds. Plant-based hemostat powders, on the other hand, are formulated from natural plant sources, reducing the likelihood of allergic reactions and sensitivities. This factor alone significantly expands the patient population that can benefit from these innovative products.

Furthermore, healthcare providers are increasingly cognizant of the importance of minimizing potential allergenic responses in their patients. By opting for plant-based hemostat powders, clinicians can offer a safer alternative that mitigates the risk of adverse reactions. This proactive approach not only enhances patient safety but also instills confidence in both practitioners and patients regarding the choice of hemostatic agents.

In addition, the rising prevalence of allergies and sensitivities in the general population has underscored the need for allergen-free medical solutions. Patients are now more informed and concerned about the substances used in their healthcare treatments. Plant-based hemostat powders provide a solution that addresses these concerns. They offer a hypoallergenic option that can be confidently used across a broad spectrum of patients, regardless of their allergy history.

Moreover, the awareness of allergies and sensitivities extends beyond individual patient considerations. Healthcare facilities and institutions are increasingly focused on providing treatments and materials that minimize risks and ensure patient well-being. Plant-based hemostat powders, being inherently hypoallergenic, align with this institutional commitment to patient safety and quality care.

Key Market Challenges

High Cost

Cost considerations pose a significant challenge for the plant-based hemostat powder market. The production of high-quality plant-based hemostat powders often involves complex and resource-intensive processes. Obtaining and processing plant materials to extract the necessary hemostatic compounds can be costly, particularly when compared to the production of traditional hemostatic agents. Advanced extraction techniques and specialized equipment may be required, adding to the initial investment for manufacturers. Additionally, ensuring the purity and potency of the extracted compounds demands rigorous quality control measures, which further contribute to production costs. These factors collectively raise the overall cost of manufacturing plant-based hemostat powders.

The economic implications extend beyond production, encompassing distribution, marketing, and pricing strategies. Manufacturers must navigate a delicate balance between offering a competitive price to healthcare providers and ensuring that it adequately covers their production expenses. This requires careful strategic planning to remain viable in the market while still providing an economically feasible option for healthcare facilities. Moreover, the cost considerations may impact accessibility and affordability for both healthcare providers and patients. If the final pricing of plant-based hemostat powders is significantly higher than that of traditional options, it could deter adoption, particularly in healthcare systems with budget constraints.

According to a study published in the National Institutes of Health's PubMed Central, the annual direct medical costs for treating patients with gastric ulcer bleeding in the United States are estimated at USD 2 billion. This highlights the substantial financial burden associated with bleeding-related medical conditions and underscores the importance of cost-effective hemostatic solutions. The high costs of traditional hemostatic agents, which can vary widely from USD 15.00 to USD 650.00, further emphasize the need for more affordable alternatives.

In summary, while plant-based hemostat powders offer promising benefits, their higher production costs compared to traditional agents present a significant challenge. Addressing these cost-related issues is crucial for enhancing the accessibility and adoption of plant-based hemostatic solutions in medical practice.

Regulatory Compliance and Approval Hamper the Growth of Plant based Hemostat Powder Market:

Regulatory compliance and approval pose significant challenges for the plant-based hemostat powder market. Navigating the intricate regulatory landscape, which varies from region to region, can be a formidable barrier to entry and growth for manufacturers in this sector. Achieving regulatory approval requires comprehensive documentation and extensive testing to demonstrate the safety, efficacy, and quality of plant-based hemostat powders. This process demands substantial financial and time investments. Small and emerging companies, which may lack the resources and infrastructure of larger corporations, may find it particularly challenging to meet these rigorous standards. As a result, some innovative plant-based hemostat powder formulations may face delays in market entry or struggle to meet the necessary regulatory requirements, impeding their availability to healthcare providers and patients. Moreover, the regulatory landscape surrounding medical devices and biologics is subject to continuous evolution. Keeping pace with changing guidelines and requirements demands a high degree of regulatory expertise and adaptability. Manufacturers must invest in dedicated regulatory affairs teams and resources to ensure ongoing compliance, which can be a significant cost for smaller companies. Global market expansion is further hindered by the need to conform to diverse regulatory frameworks. Different regions have distinct sets of standards and approval processes. Navigating these various regulatory systems adds complexity and can lead to delays in market access. Manufacturers must invest in comprehensive regulatory strategies to meet the specific requirements of each target market, potentially delaying market entry. Additionally, the stringent regulatory environment may discourage potential investors or partners from engaging with companies in the plant-based hemostat powder market. The perception of higher regulatory risk may lead to decreased investment interest, limiting funding opportunities for research, development, and market expansion.

Key Market Trends

Expansion of Applications Beyond Surgical Settings

The expansion of applications for plant-based hemostat powder beyond traditional surgical settings is significantly bolstering the market. While initially developed for surgical hemostasis, these innovative products have demonstrated their versatility and efficacy across a broader spectrum of medical disciplines. In dentistry, plant-based hemostat powder has gained traction as a valuable tool for controlling bleeding during various dental procedures. This includes extractions, periodontal surgeries, and implant placements. The precise and efficient hemostasis offered by these powders allows for more streamlined and minimally invasive dental procedures, which align with the trend towards less traumatic interventions. Additionally, the hypoallergenic nature of plant-based hemostat powder is particularly advantageous in dental applications, where patients may have heightened sensitivities or allergies to certain materials. Beyond dentistry, dermatologists are also recognizing the potential of plant-based hemostat powder in their practice. Procedures such as mole excisions, biopsies, and cosmetic dermatological interventions often require effective hemostatic solutions. The application of plant-based hemostat powder in dermatology not only ensures controlled bleeding but also reduces the risk of adverse reactions, making it a preferred choice for dermatologists and their patients. Furthermore, plant-based hemostat powder has found utility in specialties such as interventional radiology and vascular surgery. These fields often involve delicate procedures that require precise control over bleeding to achieve successful outcomes. The introduction of plant-based options provides practitioners with a safe and effective tool to enhance hemostasis, contributing to improved patient care. The adaptability of plant-based hemostat powder in a variety of medical disciplines highlights its potential to revolutionize hemostatic practices across the healthcare spectrum. As awareness of its effectiveness and hypoallergenic properties spreads within the medical community, we can anticipate further expansion of applications beyond surgical settings. This trend not only broadens the market for plant-based hemostat powder but also underscores its transformative impact on modern medical practice. As research continues and clinical evidence accumulates, the adoption of plant-based hemostat powder across diverse medical specialties is poised to grow, further solidifying its position in the healthcare landscape.

Key Market Players

Ethicon Inc.
Baxter International Inc
Becton Dickinson & Co
Bioceres SA
Grena AS/Norway
PlantTec Medical GmbH
Starch Medical Inc
Theracion Biomedical
Singclean Medical
Hemostasis, LLC

Report Scope:

In this report, the Global Plant based Hemostat Powder Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Plant based Hemostat Powder Market, By Type:

1g
3g
5g
Others

Plant based Hemostat Powder Market, By Application:

Surgical Wound Care
General Wound Care

Plant based Hemostat Powder Market, By Region:

North America
- United States
- Canada
- Mexico
Asia-Pacific
- China
- India
- South Korea
- Australia
- Japan
Europe
- Germany
- France
- United Kingdom
- Spain
- Italy
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Plant based Hemostat Powder Market.

Available Customizations:

Global Plant based Hemostat Powder Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Applications
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Impact of COVID-19 on Global Plant based Hemostat Powder Market

5. Voice of Customer

6. Global Plant based Hemostat Powder Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Type (1g, 3g, 5g, Others)
- 6.2.2. By Application (Surgical Wound Care, General Wound Care)
- 6.2.3. By Region
- 6.2.4. By Company (2024)
6.3. Market Map

7. Asia Pacific Plant based Hemostat Powder Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Type
- 7.2.2. By Application
- 7.2.3. By Country
7.3. Asia Pacific: Country Analysis
- 7.3.1. China Plant based Hemostat Powder Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Type
    - 7.3.1.2.2. By Application
- 7.3.2. India Plant based Hemostat Powder Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Type
    - 7.3.2.2.2. By Application
- 7.3.3. Australia Plant based Hemostat Powder Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Type
    - 7.3.3.2.2. By Application
- 7.3.4. Japan Plant based Hemostat Powder Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Type
    - 7.3.4.2.2. By Application
- 7.3.5. South Korea Plant based Hemostat Powder Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Type
    - 7.3.5.2.2. By Application

8. Europe Plant based Hemostat Powder Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Type
- 8.2.2. By Application
- 8.2.3. By Country
8.3. Europe: Country Analysis
- 8.3.1. France Plant based Hemostat Powder Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Type
    - 8.3.1.2.2. By Application
- 8.3.2. Germany Plant based Hemostat Powder Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Type
    - 8.3.2.2.2. By Application
- 8.3.3. Spain Plant based Hemostat Powder Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Type
    - 8.3.3.2.2. By Application
- 8.3.4. Italy Plant based Hemostat Powder Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Type
    - 8.3.4.2.2. By Application
- 8.3.5. United Kingdom Plant based Hemostat Powder Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Type
    - 8.3.5.2.2. By Application

9. North America Plant based Hemostat Powder Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Type
- 9.2.2. By Application
- 9.2.3. By Country
9.3. North America: Country Analysis
- 9.3.1. United States Plant based Hemostat Powder Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Type
    - 9.3.1.2.2. By Application
- 9.3.2. Mexico Plant based Hemostat Powder Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Type
    - 9.3.2.2.2. By Application
- 9.3.3. Canada Plant based Hemostat Powder Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Type
    - 9.3.3.2.2. By Application

10. South America Plant based Hemostat Powder Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Type
- 10.2.2. By Application
- 10.2.3. By Country
10.3. South America: Country Analysis
- 10.3.1. Brazil Plant based Hemostat Powder Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Type
    - 10.3.1.2.2. By Application
- 10.3.2. Argentina Plant based Hemostat Powder Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Type
    - 10.3.2.2.2. By Application
- 10.3.3. Colombia Plant based Hemostat Powder Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Type
    - 10.3.3.2.2. By Application

11. Middle East and Africa Plant based Hemostat Powder Market Outlook

11.1. Market Size & Forecast
- 11.1.1. By Value
11.2. Market Share & Forecast
- 11.2.1. By Type
- 11.2.2. By Application
- 11.2.3. By Country
11.3. MEA: Country Analysis
- 11.3.1. South Africa Plant based Hemostat Powder Market Outlook
  - 11.3.1.1. Market Size & Forecast
    - 11.3.1.1.1. By Value
  - 11.3.1.2. Market Share & Forecast
    - 11.3.1.2.1. By Type
    - 11.3.1.2.2. By Application
- 11.3.2. Saudi Arabia Plant based Hemostat Powder Market Outlook
  - 11.3.2.1. Market Size & Forecast
    - 11.3.2.1.1. By Value
  - 11.3.2.2. Market Share & Forecast
    - 11.3.2.2.1. By Type
    - 11.3.2.2.2. By Application
- 11.3.3. UAE Plant based Hemostat Powder Market Outlook
  - 11.3.3.1. Market Size & Forecast
    - 11.3.3.1.1. By Value
  - 11.3.3.2. Market Share & Forecast
    - 11.3.3.2.1. By Type
    - 11.3.3.2.2. By Application